(Q39817736)

14 September 2017

1 reference

title

CEA-related antigens: molecular biology and clinical significance (English)

1 reference

14 September 2017

0 references

Shively JE

1

1 reference

PubMed ID

3886178

14 September 2017

Beatty JD

series ordinal

2

1 reference

14 September 2017

1 January 1985

1 reference

Critical Reviews in Oncology Hematology

14 September 2017

1 reference

14 September 2017

2

1 reference

14 September 2017

4

1 reference

14 September 2017

355-399

1 reference

DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES

14 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Carcinoembryonic antigen (CEA) in clinical medicine.Historical perspectives, pitfalls and projections

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Specific carcinoembryonic antigens of the human digestive system

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Physicochemical studies of the carcinoembryonic antigens of the human digestive system

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Detection by Immunofluorescence of Carcinoembryonic Antigen in Colonic Carcinoma, Other Malignant or Benign Tumours, and Non-Cancerous Tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Isolation and characterization of carcinoembryonic antigen (CEA) extracted from normal human colon mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Carcinoembryonic antigen in normal human saliva.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Isolation from human gastric juice of an antigen closely related to the carcinoembryonic antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Elevated levels of carcinoembryonic antigen in cord plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Editorial: CEA-S-a more specific CEA?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Carcinoembryonic antigen: isolation of a sub-fraction with high specific activity

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Carcinoembryonic antigen: evidence for multiple antigenic determinants and isoantigens

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Electron microscopy and physical characterization of the carcinoembryonic antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Isolation and characterization for carcinoembryonic antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Heterogeneity of the carcinoembryonic antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Structural studies of the major glycoprotein in preparations with carcinoembryonic antigen activity

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Carcinoembryonic antigen (CEA): demonstration of a partial identity between CEA and a normal glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Immunological study of carcinoembryonic antigen (CEA) and a related glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Studies on carcinoembryonic antigen (CEA) and a related glycoprotein, CCEA-2. Preparation and chemical characterisation.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Carcinoembryonic antigen (CEA) and related antigens in blood cells and hematopoietic tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Nonspecific cross reacting antigen as a marker for human polymorphs, macrophages and monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

A comparative study of the localization of CEA and NCA2 in cancerous and normal gastrointestinal tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Proteolytic release of antigenic fragments corresponding to normal fecal antigen and non-specific cross-reacting antigen from carcinoembryonic antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Immunological characterization and structural studies of normal fecal antigen-1 related to carcinoembryonic antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Preparation and evaluation of antisera directed against cancer specific moiety of antigenic determinants on carcinoembryonic antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Carcinoembryonic antigen-like substances of human bile. Isolation and partial characterization

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Purification and properties of biliary glycoprotein I (BGP I). Immunochemical relationship to carcinoembryonic antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Immunological and radioimmunological studies of membrane antigen(s) from human breast carcinomas and non-tumoral breast tissues. I

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Immunological and radioimmunological studies of membrane antigen(s) from human breast carcinomas and non-tumoral breast tissues. II

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Characterization of a variant of carcinoembryonic antigen (CEA) using monoclonal and polyclonal anti-CEA antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Nature of carcinoembryonic antigen purified from malignant ascitic fluid of serous cystadenocarcinoma of the ovary

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Demonstration of an Antigen Common to Several Varieties of Neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Carcinoembryonic antigen (CEA) in non digestive cancerous and normal tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Carcinoembryonic antigen (CEA) activity in pancreatic juice of patients with pancreatic carcinoma and pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Association of medullary carcinoma of the thyroid with carcinoembryonic antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

CEA and non-specific cross-reacting antigen (NCA) in medullary carcinomas of the thyroid

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Radioimmune assay of carcinoembryonic antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Heterogeneity of carcinoembryonic antigen. II. Monosaccharide composition of concanavalin A-reactive and -nonreactive CEA

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

The purification of carcinoembryonic antigen by glutaraldehyde cross-linked concanavalin A

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Carcinoembryonic antigen (cea) of human tissue extracts: Partial characterization of two variants separated by affinity chromatography on Concanavalin A

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Immunological and chemical studies on sub-fractions of carcinoembryonic antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Immunoadsorbent purification of the carcinoembryonic antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Chemical deglycosylation of carcinoembryonic antigen for amino acid sequence studies

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Structural studies on carcinoembryonic antigen periodate oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Multiple Smith-degradations of carcinoembryonic antigen (CEA) and of asialo CEA

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Synthesis in E. coli of a polypeptide with human leukocyte interferon activity

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Human leukocyte interferon produced by E. coli is biologically active

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Carcinoembryonic antigen production by human colorectal adenocarcinoma cells in matrix-perfusion culture

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Human colonic adenocarcinoma cells. I. Establishment and description of a new line

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Continuous Production of Carcinoembryonic Antigen in Hollow Fiber Cell Culture Units: Brief Communication 2 3

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Human colon adenocarcinoma cells. II. Tumorigenic and organoid expression in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Further Biologic Characteristics of a Human Carcinoembryonic Antigen-Producing Colon Carcinoma Cell Line2

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Cultural and Antigenic Properties of Newly Established Cell Strains Derived From Adenocarcinomas of the Human Colon and Rectum

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Enhancement of carcinoembryonic antigen expression by interferon

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Immunohistology of the Antigenic Pattern of a Continuous Cell Line From a Human Colon Tumor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Characterization of WiDr: A human colon carcinoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Carcinoembryonic antigen (CEA) expression in somatic cell hybrids

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

GW-39: a new human tumor serially transplantable in the golden hamster

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Detection of circulating tumor antigens

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Somatic-cell hybrids producing antibodies against CEA.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Specificities and binding properties of eight monoclonal antibodies against carcinoembryonic antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Immunological similarity of CEA with alpha 1-acid glycoprotein (orosomucoid)

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

First British standard for carcinoembryonic antigen (CEA)

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

A simplified solid-phase radioimmunoassay for carcinoembryonic antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Radioimmunoassay of carcinoembryonic antigen (CEA) without extraction and dialysis using solid-phase antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Carcinoembryonic antigen (CEA): Comparison of the farr and solid-phase methods for detection of CEA

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Radioimmunoassay methods for carcinoembryonic antigen.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Improved performance of a double antibody radioimmunoassay for carcinoembryonic antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Semi-automatic solid-phase radioimmunoassay for carcinoembryonic antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Factors which influence the radioimmunoassay of carcinoembryonic antigen (CEA)

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

A Clinical Evaluation of the Triple-isotope Double-antibody Radioimmunoassay for Carcinoembryonic Antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

A direct competitive binding radioimmunoassay for carcinoembryonic antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Avidin as a precipitant for biotin-labeled antibody in a radioimmunoassay for carcinoembryonic antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Effect of polyethylene glycol on the rate of immune complex formation by non-precipitating antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Radioimmunological characterization of carcinoembryonic antigen (CEA) preparations.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Detection of antibody to carcinoembryonic antigen by the hemolytic plaque assay

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

“Release radioimmunoassay”: Description of a new method and its application to the determination of human chorionic somatomammotropin plasma levels

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Enzyme-linked immunosorbent assay (ELISA) quantitative assay of immunoglobulin G

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Monoclonal antibodies against carcinoembryonic antigen (CEA) used in a solid-phase enzyme immunoassay. First clinical results

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Development of solid-phase immunoassay using chemiluminescent IgG conjugates

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Sensitive enzyme assays based on the production of chemiluminescent leaving groups

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

A luminol-assisted, competitive-binding immunoassay of human immunoglobulin G.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Light emission techniques for the microestimation of femtogram levels of peroxidase. Application to peroxidase (and other enzymes)-coupled antibody-cell antigen interactions

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Enzyme immunoassays with special reference to ELISA techniques

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Homogeneous enzyme immunoassay for proteins employing beta-galactosidase

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

PEROXIDASE-LABELED ANTIBODY A NEW METHOD OF CONJUGATION

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Enzyme coupled immunoassay of insulin using a novel coupling reagent

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Comparison of two methods of preparing enzyme-antibody conjugates: Application of these conjugates for enzyme immunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Analysis of human sera for carcinoembryonic antigen (CEA) binding proteins by affinity chromatography with CEA-agarose

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

K cell mediated lysis of cultured colon carcinoma and urinary bladder carcinoma cells induced by monospecific antisera against carcinoembryonic antigen (CEA) and two CEA-related normal glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Neuraminidase-Augmented Anticarcinoembryonic Antigen (CEA)-Complement Lysis of Human Colon Tumor Cells: Lack of Correlation With Anti-CEA-Mediated K-Cell Lysis and Iodine-125 Binding2

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Carcinoembryonic antigen (CEA) in gastrointestinal and extragastrointestinal tumors and its relationship to tumor-cell differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Tissue Localization of Zinc Glycinate Marker and Carcinoembryonic Antigen by Immunofluorescence. II. Immunofluorescence Microscopy 2

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Immunohistopathologic study on carcinoembryonic antigen (CEA)-like material and immunoglobulin a in gastric malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

The demonstration of carcinoembryonic antigen in colorectal carcinoma and colonic polyps using an immunoperoxidase technique

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Tissue demonstration of carcinoembryonic antigen (CEA) in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Localization by immunoperoxidase and estimation by radioimmunoassay of carcinoembryonic antigen in colonic polyps

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Presence of carcinoembryonic antigen (CEA) in the normal and inflamed human parotid gland. An immunohistochemical study of 31 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Carcinoembryonic antigen in sweat-gland carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Briel Communication : Location by Immunoelectron Microscopy of Carcinoembryonic Antigen on Cultured Adenocarcinoma Cells 2

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Carcinoembryonic antigen (CEA) in the normal human small intestine: a light and electron microscopic study

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Carcinoembryonic antigen (CEA) assay. A laboratory adjunct in the diagnosis and management of cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Circulating CEA levels in patients with fulminant hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Clinical value of carcinoembryonic antigen: diagnosis, prognosis, and follow-up of patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Clinical significance of the preoperative plasma carcinoembryonic antigen (CEA) level in patients with carcinoma of the large bowel

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Carcinoembryonic antigen levels as an indicator of the primary site in metastatic disease of unknown origin

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Carcinoembryonic antigen producing cultured cell lines enable detection of autoantibodies in sera from patients with gastrointestinal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Carcinoembryonic antigen assay in thyroid screening

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Elevated levels of circulating carcinoembryonic antigen in hypothyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Prognostic value of preoperative serum CEA level compared to clinical staging. I. Colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Prognostic value of preoperative serum CEA level compared to clinical staging: II. Stomach cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Plasma cea levels in small cell lung cancer. Correlation with stage, distribution of metastases, and survival

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Carcinoembryonic antigen serum levels in patients with squamous cell carcinoma of the uterine cervix: clinical significance

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Oncofoetal antigens in cancer of the cervix and ovary

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Clinical significance of measurements of carcinoembryonic antigen in serum of patients with carcinoma of the uterine cervix

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Plasma CEA in the post-surgical monitoring of colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Areas of failure found at reoperation (second or symptomatic look) following "curative surgery" for adenocarcinoma of the rectum. Clinicopathologic correlation and implications for adjuvant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

A retrospective and prospective study of serial CEA determinations in the early detection of recurrent colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Sequential carcinoembryonic antigen levels. A predictor of response and relapse in combination chemotherapy of advanced gastrointestinal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

The value of the CEA test in the diagnosis of metastases of adenocarcinoma of the gastroenteric tract

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Correlation of Plasma CEA and CEA tissue staining in poorly differentiated colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Carcinoembryonic antigen as a marker in patients with breast cancer receiving postsurgical adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Quantitation of response to therapy in patients with metastatic breast carcinoma by serial analysis of plasma gross cystic disease fluid protein and carcinoembryonic antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Serial plasma carcinoembryonic antigen measurements during treatment of metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Multiple biologic markers in the monitoring of treatment for patients with small cell carcinoma of the lung: The use of serial levels of plasma cea and serum carbohydrates

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Plasma carcinoembryonic antigen in the diagnosis and management of patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Evaluation of PSβ1G and other Tumor Markers in Germ Cell Tumors of the Testis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

The relationship of the possible hepatic toxicity of chemotherapeutic drugs and carcinoembryonic antigen elevation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Measurement of Tennessee antigen, carcinoembryonic antigen, tissue polypeptide antigen and alpha-feto-protein in body fluids associated with pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Carcinoembryonic antigen present in human eccrine sweat

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Carcinoembryonic antigen (CEA) in gastric juice or feces as an aid in the diagnosis of gastrointestinal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Duodenal carcinoembryonic antigen in patients with benign and malignant diseases: preliminary observations

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Combined endoscopic pancreatic fluid collection and retrograde pancreatography in the diagnosis of pancreatic cancer and chronic pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

The Clinical Utility of Plasma and Urinary Carcinoembryonic Antigen in Patients with Genitourinary Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

The clinical value of urinary carcinoembryonic antigen-like substances in urothelial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Carcinoembryonic Antigen and Bladder Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Urinary CEA for prediction of survival time and recurrence in bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Meningeal metastasis from rectal carcinoma with elevated cerebrospinal fluid carcinoembryonic antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Subretinal fluid examination of LDH, PGI, and CEA in a case of metastatic bronchogenic carcinoma of the choroid

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Diagnostic value of tumoral markers in serous effusions. Carcinoembryonic antigen, alpha1-acidglycoprotein, alpha-fetoprotein, phosphohexose isomerase, and Beta2-microglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Simultaneous enzyme immunoassay of carcinoembryonic antigen in pleural effusion and serum

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Combined effusion fluid tumor marker assay, carcinoembryonic antigen (CEA) and human chorionic gonadotropin (HCG), in the detection of malignant tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Fetal and oncofetal antigens — Regulators of immune reactions

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Immunocytochemical localization of carcinoembryonic antigen in benign and malignant colorectal tissues. Assessment of diagnostic value

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Correlation of carcinoembryonic antigen in tissue sections with spread of mammary carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Carcinoembryonic antigen in breast-cancer tissue: a useful prognostic indicator

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Carcinoembryonic antigen localization in benign and malignant transitional epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Immunohistochemical demonstration of carcinoembryonic antigen (CEA) and its correlation with grading and staging on tissue sections of urinary bladder carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Immunoperoxidase detection of carcinoembryonic antigen and blood group substances in papillary transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Detection of tissue CEA-like substance as an aid in the differential diagnosis of malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Immunohistochemical detection of carcinoembryonic antigen (CEA) in parotid gland carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

The presence and distribution of carcinoembryonic antigen in tumors of human minor salivary glands

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Carcinoembryonic antigen in gynecologic patients. I. Correlation of plasma levels and tissue localization

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

CEA positivity in sera and breast tumor tissues obtained from the same patients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Relationship of serum CEA levels to tumour size and CEA content in nude mice bearing colonic-tumour xenografts

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Use of Radiolabeled Antibodies to Carcinoembryonic Antigen for the Detection and Localization of Diverse Cancers by External Photoscanning

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Tumor localization of CEA-containing human tumors in nude mice by means of monoclonal anti-CEA antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Radiolabeled fragments of monoclonal antibodies against carcinoembryonic antigen for localization of human colon carcinoma grafted into nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Radioactive labeling of antibody: a simple and efficient method

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Clinical radioimmunodetection of cancer with radioactive antibodies to human chorionic gonadotropin

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

The Role of Radioimmunodetection in the Management of Testicular Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Radioimmunolocalization of Tumours by External Scintigraphy after Administration of131I Antibody to Human Chorionic Gonadotrophin: Preliminary Communication

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Localization of choriocarcinoma by 131I-beta HCG antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Clinical studies on the radioimmunodetection of tumors containing alpha-fetoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Localization of I-131-labeled goat and primate anti-carcinoembryonic antigen(CEA) antibodies in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Tumor imaging with radioactive metal chelates conjugated to monoclonal antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Experimental studies of tumor radioimmunodetection using antibody mixtures against carcinoembryonic antigen (CEA) and colon-specific antigen-p (CSAp)

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Localization of human breast-carcinoma xenografts using antibodies to carcinoembryonic antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

The site of binding of anti-CEA antibodies to tumour CEA in vivo: an immunocytochemical and autoradiographic approach

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Second-look laparotomy based on CEA elevations in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Pre- and postoperative uses of CEA

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Predictive value of plasma CEA in patients with colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Carcinoembryonic antigen follow-up and selection of patients for second-look operation in management of gastrointestinal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Results of CEA-initiated second-look surgery for recurrent colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

Use of CEA as an indicator of early recurrence and as a guide to a selected second-look procedure in patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2885%2980008-1

7 January 2021

10.1016/S1040-8428(85)80008-1

Identifiers

DOI

1 reference

14 September 2017

1 reference

PubMed ID

3886178